No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs6777190 |
chr3:46789175-46789176 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs567039815 |
chr3:46789185-46789186 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs190545563 |
chr3:46789202-46789203 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs534955092 |
chr3:46789205-46789206 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs138637073 |
chr3:46789233-46789234 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs77996010 |
chr3:46789250-46789251 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs386660754 |
chr3:46789262-46789263 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs72899433 |
chr3:46789269-46789270 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
9 |
rs556109414 |
chr3:46789275-46789276 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs374041198 |
chr3:46789299-46789300 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs34462434 |
chr3:46789370-46789371 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs149335064 |
chr3:46789470-46789471 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs539104138 |
chr3:46789483-46789484 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs554011387 |
chr3:46789494-46789495 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs375571570 |
chr3:46789531-46789532 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs182507906 |
chr3:46789538-46789539 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs186661937 |
chr3:46789566-46789567 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs190712088 |
chr3:46789570-46789571 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs557207455 |
chr3:46789593-46789594 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs573949100 |
chr3:46789643-46789644 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs368361688 |
chr3:46789677-46789678 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs532024335 |
chr3:46789690-46789691 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs549915698 |
chr3:46789735-46789736 |
Enhancers Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs562449298 |
chr3:46789736-46789737 |
Enhancers Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs532823819 |
chr3:46789750-46789751 |
Enhancers Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs551447922 |
chr3:46789754-46789755 |
Enhancers Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs560038904 |
chr3:46789779-46789780 |
Enhancers Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs372126566 |
chr3:46789817-46789818 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs55806728 |
chr3:46789835-46789836 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs542988239 |
chr3:46789848-46789849 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs62246255 |
chr3:46789869-46789870 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs182663537 |
chr3:46789872-46789873 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs145451095 |
chr3:46790022-46790023 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs567541032 |
chr3:46790045-46790046 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs573956810 |
chr3:46790069-46790070 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs137973955 |
chr3:46790092-46790093 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs550094713 |
chr3:46790110-46790111 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs372616942 |
chr3:46790124-46790125 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs375165206 |
chr3:46790147-46790148 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs571603537 |
chr3:46790182-46790183 |
Enhancers Weak transcription
|
CpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs538701433 |
chr3:46790219-46790220 |
Enhancers Weak transcription
|
CpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs554137615 |
chr3:46790247-46790248 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs76132367 |
chr3:46790293-46790294 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs377273639 |
chr3:46790308-46790309 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs555575430 |
chr3:46790367-46790368 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs573911441 |
chr3:46790390-46790391 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs187666723 |
chr3:46790392-46790393 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs7614762 |
chr3:46790397-46790398 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
49 |
rs577563851 |
chr3:46790432-46790433 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs573264709 |
chr3:46790450-46790451 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|